METTL3 and non-small cell lung carcinoma: Since CYP19A1 plays a critical role in activating E2/ERβ signalling and promoting NSCLC metastasis, we performed in vitro experiments to validate that the expression of CYP19A1, as well as its associated migration and invasion, is dependent on the presence of METTL3.